Examining Disease Processes in Pulmonary Fibrosis and Mechanisms of Action of Novel Targeted Treatments: An Interactive 3D Animation

Big Win for Secukinumab in Polymyalgia Rheumatica

Failed trial in giant cell arteritis also published the same day

Post-Marketing Studies Document Extra VTE Risk for Baricitinib

Beefed up label warning now appears likely, though events still rare

Late-Breaking Studies at EULAR Paint Rosy Picture of Rheumatology's Future

Psoriatic arthritis biologics square off, novel molecules and mechanisms, and old drugs made new

Shingles Vaccine Might Be Less Effective in Systemic Sclerosis Patients

Prospective trial shows reduced immune response but no worsening of underlying disease

Four-Year Data Confirm Anifrolumab Efficacy in Lupus

Study focuses on interferon blocker's hematologic and serologic benefits

Case Report: Perihepatitis in a Lupus Patient -- Disease Flare or Something Else?

A young female patient presents with upper right quadrant abdominal pain, polyarthritis, and fever with rigors

Recurring Condition in This Woman Remained Undiagnosed for 13+ Years

"Great masquerader" can resemble many other dangerous diseases

NEJM Retracts Pivotal Trial of FDA-Approved Drug

— Move follows actions "inconsistent with proper research conduct," journal says

Lupus Can Cost Young Women More Years Than Diabetes, HIV

Lupus contributes substantially to premature mortality in young women, with over 304,000 years of potential life lost in women aged 15-44 years from 2000 to 2015.

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Diagnosis of IPF

From Evidence to Action: Practical Strategies for FcRn Therapy in gMG

From Evidence to Action: Practical Strategies for FcRn Therapy in gMG

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy

Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy

Transforming CIDP Management: Early Diagnosis, Pathophysiology, and the Emerging Role of FcRn Antagonists

Transforming CIDP Management: Early Diagnosis, Pathophysiology, and the Emerging Role of FcRn Antagonists

ACR: American College of Rheumatology

EULAR: European Alliance of Associations for Rheumatology